- Home
- Publications
- Publication Search
- Publication Details
Title
Challenges of NK cell-based immunotherapy in the new era
Authors
Keywords
natural killer cells, immunotherapy, adoptive transfer, genetic modification, immune checkpoint inhibitor
Journal
Frontiers of Medicine
Volume 12, Issue 4, Pages 440-450
Publisher
Springer Nature America, Inc
Online
2018-07-25
DOI
10.1007/s11684-018-0653-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adoptive transfer of natural killer cells in combination with chemotherapy improves outcomes of patients with locally advanced colon carcinoma
- (2018) Lingyu Li et al. CYTOTHERAPY
- Genetically re-engineered K562 cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapy
- (2017) Janet Ayello et al. EXPERIMENTAL HEMATOLOGY
- Donor selection for ex vivo-expanded natural killer cells as adoptive cancer immunotherapy
- (2017) Wei Wang et al. Future Oncology
- Natural Killer Cells: Angels and Devils for Immunotherapy
- (2017) Beatriz Martín-Antonio et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- NK cell-based immunotherapy for cancer
- (2017) Fang Fang et al. SEMINARS IN IMMUNOLOGY
- Chimeric antigen receptor–engineered natural killer and natural killer T cells for cancer immunotherapy
- (2017) Dominique Bollino et al. Translational Research
- Comparison of autogeneic and allogeneic natural killer cells immunotherapy on the clinical outcome of recurrent breast cancer
- (2017) Shuzhen Liang et al. OncoTargets and Therapy
- Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV
- (2017) Dongfang Liu et al. Protein & Cell
- Bioengineering Solutions for Manufacturing Challenges in CAR T Cells
- (2017) Nicole J. Piscopo et al. Biotechnology Journal
- Shaping of Natural Killer Cell Antitumor Activity by Ex Vivo Cultivation
- (2017) Markus Granzin et al. Frontiers in Immunology
- Natural Killer Cell-Based Cancer Immunotherapies: From Immune Evasion to Promising Targeted Cellular Therapies
- (2017) Erhard Hofer et al. Frontiers in Immunology
- Recent Successes and Future Directions in Immunotherapy of Cutaneous Melanoma
- (2017) Hassan Sadozai et al. Frontiers in Immunology
- The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments
- (2017) John P. Veluchamy et al. Frontiers in Immunology
- PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
- (2017) Zijun Y. Xu-Monette et al. Frontiers in Immunology
- Natural Killer T Cells in Cancer Immunotherapy
- (2017) Shiny Nair et al. Frontiers in Immunology
- Phase II Study of Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Myeloid Malignancies Following Allogeneic Hematopoietic Cell Transplantation
- (2016) Brian C. Shaffer et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status
- (2016) John P. Veluchamy et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cellular and molecular regulation of innate inflammatory responses
- (2016) Juan Liu et al. Cellular & Molecular Immunology
- Innate immunity and inflammation
- (2016) Tsan Sam Xiao Cellular & Molecular Immunology
- Human γδT-cell subsets and their involvement in tumor immunity
- (2016) Dang Wu et al. Cellular & Molecular Immunology
- NK cell education via nonclassical MHC and non-MHC ligands
- (2016) Yuke He et al. Cellular & Molecular Immunology
- Liver-infiltrating CD11b−CD27− NK subsets account for NK-cell dysfunction in patients with hepatocellular carcinoma and are associated with tumor progression
- (2016) Qiong-Fang Zhang et al. Cellular & Molecular Immunology
- Targeting KIR Blockade in Multiple Myeloma: Trouble in Checkpoint Paradise?
- (2016) M. Felices et al. CLINICAL CANCER RESEARCH
- IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function
- (2016) D. A. Vallera et al. CLINICAL CANCER RESEARCH
- Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
- (2016) Ana C. Anderson et al. IMMUNITY
- Immunotherapeutic strategies targeting natural killer T cell responses in cancer
- (2016) Susannah C. Shissler et al. IMMUNOGENETICS
- Deciphering the killer-cell immunoglobulin-like receptor system at super-resolution for natural killer and T-cell biology
- (2016) Vivien Béziat et al. IMMUNOLOGY
- Preparation of Cytokine-activated NK Cells for Use in Adoptive Cell Therapy in Cancer Patients
- (2016) Monique M. van Ostaijen-ten Dam et al. JOURNAL OF IMMUNOTHERAPY
- Secretory TRAIL-Armed Natural Killer Cell–Based Therapy: In Vitro and In Vivo Colorectal Peritoneal Carcinomatosis Xenograft
- (2016) Xinxin Song et al. MOLECULAR CANCER THERAPEUTICS
- Targeting natural killer cells in cancer immunotherapy
- (2016) Camille Guillerey et al. NATURE IMMUNOLOGY
- Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
- (2016) Rizwan Romee et al. Science Translational Medicine
- Natural Killer Cells for Therapy of Leukemia
- (2016) Garnet Suck et al. TRANSFUSION MEDICINE AND HEMOTHERAPY
- Adoptive immunotherapy against ovarian cancer
- (2016) Gloria Mittica et al. Journal of Ovarian Research
- Bispecific antibodies in cancer immunotherapy
- (2016) Siqi Chen et al. Human Vaccines & Immunotherapeutics
- Phase I Study of Random Healthy Donor-Derived Allogeneic Natural Killer Cell Therapy in Patients with Malignant Lymphoma or Advanced Solid Tumors
- (2016) Y. Yang et al. Cancer Immunology Research
- A New Biological Feature of Natural Killer Cells: The Recognition of Solid Tumor-Derived Cancer Stem Cells
- (2016) Rossana Tallerico et al. Frontiers in Immunology
- Synergy between Common γ Chain Family Cytokines and IL-18 Potentiates Innate and Adaptive Pathways of NK Cell Activation
- (2016) Carolyn M. Nielsen et al. Frontiers in Immunology
- Manufacturing Natural Killer Cells as Medicinal Products
- (2016) Christian Chabannon et al. Frontiers in Immunology
- Novel treatment strategy with autologous activated and expanded natural killer cells plus anti-myeloma drugs for multiple myeloma
- (2016) Alejandra Leivas et al. OncoImmunology
- Therapeutic CD94/NKG2A blockade improves natural killer cell dysfunction in chronic lymphocytic leukemia
- (2016) Emily M. McWilliams et al. OncoImmunology
- Highly efficient IL-21 and feeder cell-driven ex vivo expansion of human NK cells with therapeutic activity in a xenograft mouse model of melanoma
- (2016) Markus Granzin et al. OncoImmunology
- Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G
- (2016) Sareetha Kailayangiri et al. OncoImmunology
- Generation of Highly Cytotoxic Natural Killer Cells for Treatment of Acute Myelogenous Leukemia Using a Feeder-Free, Particle-Based Approach
- (2015) Jeremiah L. Oyer et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells
- (2015) Gerharda H. Boerman et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Natural Killer Cell Adoptive Transfer Therapy
- (2015) Zachary B. Davis et al. CANCER JOURNAL
- The breast tumor microenvironment alters the phenotype and function of natural killer cells
- (2015) Tamara Krneta et al. Cellular & Molecular Immunology
- A phase I/II trial of interleukin-15–stimulated natural killer cell infusion after haplo-identical stem cell transplantation for pediatric refractory solid tumors
- (2015) Antonio Pérez-Martínez et al. CYTOTHERAPY
- Expansion of NK cells from PBMCs using immobilized 4-1BBL and interleukin-21
- (2015) XIAOMEI LI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Ex Vivo–expanded Natural Killer Cells Demonstrate Robust Proliferation In Vivo in High-risk Relapsed Multiple Myeloma Patients
- (2015) Susann Szmania et al. JOURNAL OF IMMUNOTHERAPY
- Phase I clinical trial of autologous NK cell therapy using novel expansion method in patients with advanced digestive cancer
- (2015) Naoyuki Sakamoto et al. Journal of Translational Medicine
- Agonists of Co-stimulation in Cancer Immunotherapy Directed Against CD137, OX40, GITR, CD27, CD28, and ICOS
- (2015) Miguel F. Sanmamed et al. SEMINARS IN ONCOLOGY
- Anticancer Cytokines: Biology and Clinical Effects of Interferon-α2, Interleukin (IL)-2, IL-15, IL-21, and IL-12
- (2015) Theofanis Floros et al. SEMINARS IN ONCOLOGY
- Induced Pluripotent Stem Cell-Derived Natural Killer Cells for Treatment of Ovarian Cancer
- (2015) David L. Hermanson et al. STEM CELLS
- Genetic Manipulation of NK Cells for Cancer Immunotherapy: Techniques and Clinical Implications
- (2015) Mattias Carlsten et al. Frontiers in Immunology
- Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer Immunotherapy
- (2015) Cariad Chester et al. Frontiers in Immunology
- Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) – From Preclinical Studies to a Clinical Phase II Trial
- (2015) Hanno M. Specht et al. Frontiers in Immunology
- Revving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies
- (2015) Gianfranco Pittari et al. Frontiers in Immunology
- Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity
- (2015) Carin I. M. Dahlberg et al. Frontiers in Immunology
- Advances in clinical NK cell studies: Donor selection, manufacturing and quality control
- (2015) U. Koehl et al. OncoImmunology
- Enhanced targeting of stem-like solid tumor cells with radiation and natural killer cells
- (2015) Erik Ames et al. OncoImmunology
- Two-Stage Priming of Allogeneic Natural Killer Cells for the Treatment of Patients with Acute Myeloid Leukemia: A Phase I Trial
- (2015) Panagiotis D. Kottaridis et al. PLoS One
- Donor-Derived Natural Killer Cells Infused after Human Leukocyte Antigen–Haploidentical Hematopoietic Cell Transplantation: A Dose-Escalation Study
- (2014) Inpyo Choi et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein
- (2014) V. Bachanova et al. BLOOD
- Monomethyl fumarate augments NK cell lysis of tumor cells through degranulation and the upregulation of NKp46 and CD107a
- (2014) Heidi Vego et al. Cellular & Molecular Immunology
- Tracking in vivo dynamics of NK cells transferred in patients undergoing stem cell transplantation
- (2014) Monica Killig et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Cytokine-induced killer (CIK) cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC)
- (2014) Leonard Christopher Schmeel et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Clinical utility of natural killer cells in cancer therapy and transplantation
- (2014) David A. Knorr et al. SEMINARS IN IMMUNOLOGY
- Reversal of natural killer cell exhaustion by TIM-3 blockade
- (2014) Anne Gallois et al. OncoImmunology
- Effects of interleukin-18 on natural killer cells: costimulation of activation through Fc receptors for immunoglobulin
- (2013) Shivani Srivastava et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- NK cell-based immunotherapy for malignant diseases
- (2013) Min Cheng et al. Cellular & Molecular Immunology
- Treatment of patients with advanced cancer with the natural killer cell line NK-92
- (2013) Torsten Tonn et al. CYTOTHERAPY
- Ex vivo activation and expansion of natural killer cells from patients with advanced cancer with feeder cells from healthy volunteers
- (2013) Eun-Kyung Kim et al. CYTOTHERAPY
- T-helper-1-cell cytokines drive cancer into senescence
- (2013) Heidi Braumüller et al. NATURE
- Natural Killer Cells Generated from Cord Blood Hematopoietic Progenitor Cells Efficiently Target Bone Marrow-Residing Human Leukemia Cells in NOD/SCID/IL2Rgnull Mice
- (2013) Jeannette Cany et al. PLoS One
- Antigen Presenting Cell-Mediated Expansion of Human Umbilical Cord Blood Yields Log-Scale Expansion of Natural Killer Cells with Anti-Myeloma Activity
- (2013) Nina Shah et al. PLoS One
- Clinical-Scale Derivation of Natural Killer Cells From Human Pluripotent Stem Cells for Cancer Therapy
- (2013) David A. Knorr et al. Stem Cells Translational Medicine
- A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma
- (2012) D. M. Benson et al. BLOOD
- Cancer-Induced Immunosuppression: IL-18-Elicited Immunoablative NK Cells
- (2012) M. Terme et al. CANCER RESEARCH
- Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications
- (2012) Natalia Lapteva et al. CYTOTHERAPY
- Highly activated and expanded natural killer cells for multiple myeloma immunotherapy
- (2012) T. K. Garg et al. HAEMATOLOGICA
- Synergistic cytotoxicity of ex vivo expanded natural killer cells in combination with monoclonal antibody drugs against cancer cells
- (2012) Xuewen Deng et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
- (2012) Cecele J. Denman et al. PLoS One
- Autologous stem cell transplant recipients tolerate haploidentical related-donor natural killer cell-enriched infusions
- (2012) Hans Klingemann et al. TRANSFUSION
- Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients
- (2011) A. Curti et al. BLOOD
- Adoptive Transfer of Autologous Natural Killer Cells Leads to High Levels of Circulating Natural Killer Cells but Does Not Mediate Tumor Regression
- (2011) M. R. Parkhurst et al. CLINICAL CANCER RESEARCH
- Activating Signals Dominate Inhibitory Signals in CD137L/IL-15 Activated Natural Killer Cells
- (2011) Hua Zhang et al. JOURNAL OF IMMUNOTHERAPY
- Expansion of NK cells from cord blood with antileukemic activity using GMP-compliant substances without feeder cells
- (2011) J Tanaka et al. LEUKEMIA
- Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process
- (2011) Jan Spanholtz et al. PLoS One
- Natural Killer Cell-Enriched Donor Lymphocyte Infusions from A 3-6/6 HLA Matched Family Member following Nonmyeloablative Allogeneic Stem Cell Transplantation
- (2010) David A. Rizzieri et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Characterizing the anti-tumor function of adoptively transferred NK cells in vivo
- (2010) Hollie J. Pegram et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Allogeneic natural killer cells for refractory lymphoma
- (2010) Veronika Bachanova et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer
- (2010) Eleni G. Iliopoulou et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Chemotherapy-Induced Genotoxic Stress Promotes Sensitivity to Natural Killer Cell Cytotoxicity by Enabling Missing-Self Recognition
- (2010) J. H. Fine et al. CANCER RESEARCH
- A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
- (2010) Melissa A. Geller et al. CYTOTHERAPY
- NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia
- (2010) Jeffrey E. Rubnitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Generation of donor natural killer cells from CD34+ progenitor cells and subsequent infusion after HLA-mismatched allogeneic hematopoietic cell transplantation: a feasibility study
- (2009) S R Yoon et al. BONE MARROW TRANSPLANTATION
- Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial
- (2008) S. Arai et al. CYTOTHERAPY
- Autologous and allogeneic HLA KIR ligand environments and activating KIR control KIR NK-cell functions
- (2008) Maelig Morvan et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Functions of natural killer cells
- (2008) Eric Vivier et al. NATURE IMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now